webinar | patient and haematologist perspectives on minimal residual disease testing in myeloma
Published 1 year ago • 227 plays • Length 1:29:15Download video MP4
Download video MP3
Similar videos
-
3:26
how valuable is minimal residual disease testing for myeloma patients?
-
48:03
minimal residual disease (mrd) in myeloma and related diseases
-
5:46
what is minimal residual disease (mrd) in myeloma?
-
2:12
ash 2023 | minimal residual disease (mrd) measurement in myeloma
-
4:44
minimal residual disease (mrd) | high impact topic (hit)
-
1:03:05
mpe webinar | disease and treatment specificities for young myeloma patients
-
1:02:09
faqs on multiple myeloma: diagnosis & prognosis
-
47:00
common symptoms and presentations of multiple myeloma to primary care physicians
-
1:10:32
newly diagnosed multiple myeloma | diagnosis, initial treatment | asct, maintenance therapy, goals
-
48:14
faqs on minimal residual disease
-
1:36
how is minimal residual disease (mrd) testing used in myeloma care?
-
19:41
multiple myeloma: minimal residual disease
-
1:01:14
mpe webinar | eha 2024 myeloma highlights
-
11:23
challenges and future perspectives for minimal residual disease (mrd) in multiple myeloma
-
3:06
what is minimal residual testing in multiple myeloma?
-
29:23
patient seminar with prof. nikhil c. munshi: minimal residual disease in myeloma session 1
-
58:05
mpe webinar ash 2023 myeloma and al amyloidosis highlights
-
3:19
what impact have new minimal residual disease (mrd) assessment techniques had in myeloma?
-
1:02:07
paraproteinemias and myeloma - copm weekly webinar - haematology
-
21:18
finding the cure: exploring the potential of mrd as a novel endpoint
-
46:20
immunotherapy for multiple myeloma, with hearn jay cho
-
46:00
current and future treatment of multiple myeloma